| Titolo |
Pubblicato in |
Anno |
| Novel pyridine-containing histone deacetylase inhibitors strongly arrest proliferation, induce apoptosis and modulate miRNAs in cancer cells |
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY |
2022 |
| Selenium-Containing Agents Acting on Cancer—A New Hope? |
PHARMACEUTICS |
2022 |
| Novel quinoline compounds active in cancer cells through coupled DNA methyltransferase inhibition and degradation |
CANCERS |
2020 |
| Tranylcypromine-based LSD1 inhibitors: structure-activity relationships, antiproliferative effects in leukemia, and gene target modulation |
CHEMMEDCHEM |
2020 |
| Targeting the scaffolding role of LSD1 (KDM1A) poises acute myeloid leukemia cells for retinoic acid-induced differentiation |
SCIENCE ADVANCES |
2020 |
| Design of first-in-class dual EZH2/HDAC inhibitor: biochemical activity and biological evaluation in cancer cells |
ACS MEDICINAL CHEMISTRY LETTERS |
2020 |
| Targeting histone acetylation/deacetylation in parasites: an update (2017–2020) |
CURRENT OPINION IN CHEMICAL BIOLOGY |
2020 |
| Properly substituted cyclic Bis-(2-bromobenzylidene) compounds behaved as dual p300/CARM1 Inhibitors and Induced apoptosis in cancer cells |
MOLECULES |
2020 |
| CDK9 as a valuable target in cancer: from natural compounds inhibitors to current treatment in pediatric soft tissue sarcomas |
FRONTIERS IN PHARMACOLOGY |
2020 |
| Novel Pyridine-Based Hydroxamates and 2'-Aminoanilides as Histone Deacetylase Inhibitors: Biochemical Profile and Anticancer Activity |
CHEMMEDCHEM |
2020 |
| Identification of a novel quinoline-based DNA demethylating compound highly potent in cancer cells |
CLINICAL EPIGENETICS |
2019 |
| design, synthesis, antiviral evaluation, and SAR studies of new 1-(phenylsulfonyl)-1H-pyrazol-4-yl-methylaniline derivatives |
FRONTIERS IN CHEMISTRY |
2019 |
| Dissecting the role of novel EZH2 inhibitors in primary glioblastoma cell cultures: effects on proliferation, epithelial-mesenchymal transition, migration, and on the pro-inflammatory phenotype |
CLINICAL EPIGENETICS |
2019 |
| Histone deacetylases contribute to excitotoxicity-triggered degeneration of retinal ganglion cells in vivo |
MOLECULAR NEUROBIOLOGY |
2019 |
| Histone deacetylases as an epigenetic pillar for the development of hybrid inhibitors in cancer |
CURRENT OPINION IN CHEMICAL BIOLOGY |
2019 |
| Six years (2012-2018) of researches on catalytic EZH2 inhibitors: the boom of the 2-pyridone compounds |
THE CHEMICAL RECORD |
2018 |
| Inhibitors of yellow fever virus replication based on 1,3,5-triphenyl-4,5-dihydropyrazole scaffold: design, synthesis and antiviral evaluation |
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY |
2017 |
| (E)-3-Heteroarylidenechroman-4-ones as potent and selective monoamine oxidase-B inhibitors |
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY |
2016 |
| 3-(Phenyl-4-oxy)-5-phenyl-4,5-dihydro-(1H)-pyrazole: a fascinating molecular framework to study the enantioseparation ability of the amylose (3,5-dimethylphenylcarbamate) chiral stationary phase. Part I. Structure-enantioselectivity relationships |
JOURNAL OF CHROMATOGRAPHY A |
2016 |
| N-((1,3-diphenyl-1H-pyrazol-4-yl)methyl)anilines: a novel class of anti-RSV agents |
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS |
2015 |
